tafamidis
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
12 FDA-registered drug labelers
Alivus Life Sciences Limited
Aurobindo Pharma Limited
Biophore India Pharmaceuticals Pvt. Ltd
Catalent Micron Technologies, Inc.
Catalent Pharma Solutions, LLC
MSN Laboratories Private Limited
Neuland Laboratories Limited
NURAY CHEMICALS PRIVATE LIMITED
Pfizer Asia Manufacturing Pte Ltd
Pfizer Ireland Pharmaceuticals Unlimited Company
Pfizer Laboratories Div Pfizer Inc
TAPI Croatia Industries Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Vyndamax
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No Shortage
Shortage History
Each row is a separate manufacturer's FDA shortage filing — not a timeline for the drug as a whole. Multiple "current" entries are normal: each manufacturer/NDC files independently. Status reflects the manufacturer's report; reason describes their supply situation (Available, Unavailable, or to be discontinued).
to be discontinued
Tafamidis Meglumine Capsule
09/29/2025Vendor Pricing
$27.60/gAaron Chemicals LLC
CountryHong Kong
Pack$138.00 / 5 g
Purity98%
Vendors20 available
Prices reflect listed pack sizes. Small research packs run far above bulk rates.
19 more vendors
| Vendor | Country Supplier country. Where available, shows shipping origin. When the supplier ships from a different country than where they are registered, both are shown. Most suppliers show registration country only. | $/g | Pack | Purity |
|---|---|---|---|---|
| A2B Chem LLC | United States | $30.00 | 25 g | 98% |
| Angene Chemical | China → Hong Kong | $31.60 | 25 g | 98% |
| BLD Pharmatech Ltd. | China | $31.68 | 100 g | 98% |
| AA BLOCKS | United States | $33.40 | 25 g | 98% |
| Ambeed, Inc. | United States | $34.85 | 100 g | 98% |
| BLD Pharmatech Co., Limited | United States | $42.24 | 25 g | 98% |
| BLD Pharmatech GmbH | Germany | $42.24 | 25 g | 98% |
| Combi-Blocks, Inc. | United States | $42.24 | 25 g | 98% |
| AstaTech, Inc | United States | $95.60 | 5 g | 98% |
| Angene International Limited | United States | $329.00 | 1 g | 98% |
| MedKoo Biosciences, Inc | United States | $1975.00 | 2 g | 98% |
| Angene | China → Hong Kong | $2500.00 | 30 mg | 98% |
| Molnova | China | $3320.00 | 100 mg | 99% |
| TargetMol Chemicals | China → United States | $3690.00 | 100 mg | 99.65% |
| MedChemExpress MCE | Sweden | $6183.10 | 100 mg | 99.89% |
| Axon Medchem | Netherlands | $6480.00 | 50 mg | 99% |
| Cayman Europe | Estonia | $12566.40 | 50 mg | 98% |
| AK Scientific Specialized | United States | $17000.00 | 5 mg | 95% |
| AK Scientific, Inc. | United States | $23200.00 | 5 mg | 98% |
Chemical Identity
CAS594839-88-0
PubChem CID11001318
DTXSIDDTXSID00208185
FormulaC14H7Cl2NO3
Mol. Weight308.1 g/mol
SMILESC1=CC2=C(C=C1C(=O)O)OC(=N2)C3=CC(=CC(=C3)Cl)Cl
Data Sources
110013182026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/tafamidis/cids/JSON
Archive: data/sources/pubchem_name/tafamidis.json
CAS 594839-88-02026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
CAS 594839-88-02026-06-13
https://api.fda.gov/drug/shortages.json
Archive: data/sources/fda/shortages/shortages.json